Zenith Drugs (ZENITHDRUG) Shareholding Pattern

NSE: ZENITHDRUG • Promoter, FII, DII Holdings for Tickjournal
Promoter Holding 69.98%
FII Holding 0.00%
DII Holding 0.00%
Public Holding 25.25%
Total Shareholders 1,466
As of Sept 2025
View the latest shareholding pattern of Zenith Drugs (ZENITHDRUG) including promoter, FII, DII, and public holdings. Track ZENITHDRUG ownership changes over time and document your investment thesis in Tickjournal — your personal trade journal. (See ZENITHDRUG annual price range)

Zenith Drugs (ZENITHDRUG) Shareholding Summary

  • Promoter holding remains unchanged at 69.98% in Sept 2025
  • FII/FPI holding remains unchanged at 0.00% in Sept 2025
  • DII holding remains unchanged at 0.00% in Sept 2025
  • Public holding has decreased from 25.56% to 25.25% in Sept 2025
  • Number of shareholders decreased from 1,544 to 1,466 in Sept 2025

ZENITHDRUG Quarterly Ownership Changes

Quarter-over-quarter changes for Zenith Drugs from Mar 2025 to Sept 2025.

Promoter Holding Change
Mar 2025 to Sept 2025
No Change
FII Holding Change
Mar 2025 to Sept 2025
No Change
DII Holding Change
Mar 2025 to Sept 2025
No Change
Public Holding Change
Mar 2025 to Sept 2025
-0.31%

Zenith Drugs (ZENITHDRUG) Quarterly Shareholding Trends

Visual breakdown of ZENITHDRUG ownership distribution over time. Learn more about ZENITHDRUG market cap trends.

Promoter
FII
DII
Public
Government

Rising institutional holdings in ZENITHDRUG often correlate with improved fundamentals. Check out ZENITHDRUG quarterly financials.

Zenith Drugs (ZENITHDRUG) Shareholding Data

Download complete ZENITHDRUG ownership data for offline analysis. Discover Zenith Drugs value estimation.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Sept 2025 69.98% 0.00% 0.00% 0.00% 25.25% 4.77% 100.00% 1,466
Mar 2025 69.98% 0.00% 0.00% 0.00% 25.56% 4.46% 100.00% 1,544
Sept 2024 69.98% 0.00% 0.00% 0.00% 25.57% 4.45% 100.00% 1,355
Mar 2024 69.98% 0.00% 0.00% 0.00% 15.20% 14.83% 100.01% 1,117
Feb 2024 100.00% 0.00% 0.00% 0.00% 0.00% 0.00% 100.00% 7
Sept 2023 100.00% 0.00% 0.00% 0.00% 0.00% 0.00% 100.00% 7

ZENITHDRUG promoter holding above 50% indicates strong insider confidence. Explore the ZENITHDRUG book value for detailed insights.

Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Sept 2025 69.98% 0.00% 0.00% 0.00% 25.25% 4.77% 100.00% 1,466
Mar 2025 69.98% 0.00% 0.00% 0.00% 25.56% 4.46% 100.00% 1,544
Sept 2024 69.98% 0.00% 0.00% 0.00% 25.57% 4.45% 100.00% 1,355
Mar 2024 69.98% 0.00% 0.00% 0.00% 15.20% 14.83% 100.01% 1,117
Feb 2024 100.00% 0.00% 0.00% 0.00% 0.00% 0.00% 100.00% 7
Sept 2023 100.00% 0.00% 0.00% 0.00% 0.00% 0.00% 100.00% 7

Quarterly data helps track institutional investment cycles.

Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2025 69.98% 0.00% 0.00% 0.00% 25.56% 4.46% 100.00% 1,544
Mar 2024 69.98% 0.00% 0.00% 0.00% 15.20% 14.83% 100.01% 1,117

Year-over-year trends reveal long-term ownership shifts.

Understanding Zenith Drugs (ZENITHDRUG) Shareholding Pattern

Zenith Drugs shareholding pattern reveals who owns ZENITHDRUG stock and how ownership changes over time. High promoter stakes in ZENITHDRUG often signal management confidence, while rising FII/DII holdings suggest growing institutional interest. Use Tickjournal to log these insights alongside your ZENITHDRUG trades. Zenith Drugs price earnings

Combine ZENITHDRUG ownership analysis with price movements and financial performance for a complete investment picture. (See Zenith Drugs dividend policy)